相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Iason Psilopatis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Eph Receptors in Cancer
Sakshi Arora et al.
BIOMEDICINES (2023)
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach
Francesca Romana Ferrari et al.
BIOCHEMICAL PHARMACOLOGY (2023)
Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer
Alix Troster et al.
CHEMMEDCHEM (2023)
Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells
Riza Serttas et al.
MEDICAL ONCOLOGY (2023)
Animal models of bone metastatic prostate cancer
Jong Hyun Tae et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2023)
Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer
Mei Yang et al.
MEDICAL ONCOLOGY (2022)
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw
Veronica Mollica et al.
CURRENT ONCOLOGY (2022)
The Role of the Eph Receptor Family in Tumorigenesis
Meg Anderton et al.
CANCERS (2021)
The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
Alexandros Pergaris et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
Oscar J. Buckens et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Ephrin or not? Six tough questions on Eph targeting
Carmine Giorgio et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
Ahmed F. Salem et al.
CANCERS (2020)
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
Giorgia Zadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction
Carmine Giorgio et al.
BIOCHEMICAL PHARMACOLOGY (2018)
TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression
Yuyang Sun et al.
MOLECULAR CARCINOGENESIS (2018)
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
Claudio Festuccia et al.
Oncotarget (2018)
Targeting Eph/ephrin system in cancer therapy
Alessio Lodola et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
Jose Alexandre Ferreira et al.
DRUG RESISTANCE UPDATES (2016)
Mechanisms of ephrin-Eph signalling in development, physiology and disease
Artur Kania et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells
Sang-Hun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system
Riccardo Castelli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
In PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I
Miao Yu et al.
SCIENTIFIC REPORTS (2015)
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations
I. Hassan-Mohamed et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein-Protein Antagonists
Massimiliano Tognolini et al.
CHEMMEDCHEM (2014)
Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling
Ji-Fan Lin et al.
CARCINOGENESIS (2013)
Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
T. Tawadros et al.
BRITISH JOURNAL OF CANCER (2012)
A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
Aaron Petty et al.
PLOS ONE (2012)
Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells
Nai-Ying Yang et al.
CELLULAR SIGNALLING (2011)
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
Carmine Giorgio et al.
PLOS ONE (2011)
PC3 Is a Cell Line Characteristic of Prostatic Small Cell Carcinoma
Sheng Tai et al.
PROSTATE (2011)
Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations
Hong Ji et al.
PROTEOMICS (2011)
EphB Signaling Controls Lineage Plasticity of Adult Neural Stem Cell Niche Cells
Tadashi Nomura et al.
CELL STEM CELL (2010)
Ephrins Negatively Regulate Cell Proliferation in the Epidermis and Hair Follicle
Maria Genander et al.
STEM CELLS (2010)
Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors
Cynthia Kosinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells
Sanjeev Shukla et al.
CELL CYCLE (2007)
EphA-ephrin-A-mediated β cell communication regulates insulin secretion from pancreatic islets
Irena Konstantinova et al.
CELL (2007)
Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines
BP Fox et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred
N Prevost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)